Skip to main content
Ivan Cakulev, MD, Cardiology, Cleveland, OH

IvanTCakulevMD

Cardiology Cleveland, OH

Adult Congenital Heart Disease, Cardiac Electrophysiology

Assistant Professor, Medicine, Case Western Reserve University School of Medicine

Dr. Cakulev is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Cakulev's full profile

Already have an account?

  • Office

    11100 Euclid Ave
    Cleveland, OH 44106
    Phone+1 216-844-8500

Education & Training

  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2002 - 2004
  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Cardiovascular Disease, 1998 - 2002
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 1994 - 1997
  • Other
    OtherClass of 1993
  • University Kiril and Metodij Faculty of Medicine
    University Kiril and Metodij Faculty of MedicineClass of 1992

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2002 - 2025
  • TX State Medical License
    TX State Medical License 2000 - 2003
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Clinical Cardiac Electrophysiology

Publications & Presentations

PubMed

Press Mentions

  • University Hospitals Using New Heart Failure Therapy Designed to Improve Patients’ Quality of Life
    University Hospitals Using New Heart Failure Therapy Designed to Improve Patients’ Quality of LifeJuly 6th, 2021
  • Ohio Health System Among 1st in US to Use Novel Heart Failure Therapy
    Ohio Health System Among 1st in US to Use Novel Heart Failure TherapyJune 22nd, 2021